(Q36039437)

11 August 2017

Cisplatin-loaded porous Si microparticles capped by electroless deposition of platinum (English)

1 reference

11 August 2017

1 reference

Jennifer S Park

1

1 reference

11 August 2017

Joseph M Kinsella

2

1 reference

11 August 2017

Danielle D Jandial

3

1 reference

11 August 2017

Stephen B Howell

4

1 reference

11 August 2017

Michael J Sailor

5

1 reference

11 August 2017

1 June 2011

1 reference

11 August 2017

1 reference

11 August 2017

7

1 reference

11 August 2017

14

1 reference

11 August 2017

2061-2069

1 reference

Real-time monitoring of sustained drug release using the optical properties of porous silicon photonic crystal particles

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3377373

Polymer--cisplatin conjugate nanoparticles for acid-responsive drug delivery

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3377373

Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3377373

Biodegradable luminescent porous silicon nanoparticles for in vivo applications

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3377373

Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3377373

Oxidation-triggered release of fluorescent molecules or drugs from mesoporous Si microparticles.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3377373

Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3377373

Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drug-delivery vehicle

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3377373

Failure of MTT as a toxicity testing agent for mesoporous silicon microparticles

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3377373

Cisplatin-incorporated hyaluronic acid nanoparticles based on ion-complex formation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3377373

Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3377373

Soluble single-walled carbon nanotubes as longboat delivery systems for platinum(IV) anticancer drug design

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3377373

Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3377373

Cisplatin delivery from poly(acrylic acid-co-methyl methacrylate) microparticles.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3377373

Synthesis, characterization, and cytotoxicity of a series of estrogen-tethered platinum(IV) complexes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3377373

Platinum-based anticancer agents: innovative design strategies and biological perspectives.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3377373

Platinum Compounds: a New Class of Potent Antitumour Agents

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3377373

Activation of programmed cell death by anticancer agents: cisplatin as a model system

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3377373

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3377373

Protein interactions with platinum-DNA adducts: from structure to function

27 July 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201100438

Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201100438

Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201100438

Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201100438

Phase I and pharmacokinetic trial of AP5346, a DACH-platinum-polymer conjugate, administered weekly for three out of every 4 weeks to advanced solid tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201100438

A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201100438

Enzyme-responsive snap-top covered silica nanocontainers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201100438

PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201100438

Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201100438

Microfabricated porous silicon particles enhance paracellular delivery of insulin across intestinal Caco-2 cell monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201100438

Engineering the chemistry and nanostructure of porous silicon Fabry-Pérot films for loading and release of a steroid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201100438

Nanostructured surface modification of ceramic-based microelectrodes to enhance biocompatibility for a direct brain-machine interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201100438

Surface-Enhanced Raman Scattering from Silver-Plated Porous Silicon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201100438

A porous silicon-palladium composite film for optical interferometric sensing of hydrogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201100438

Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): phase I study.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3377373

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

23 September 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201100438

Rates of platination of -AG- and -GA- containing double-stranded oligonucleotides: effect of chloride concentration

21 January 2018

1 reference

12 December 2020

Scanometric DNA Array Detection with Nanoparticle Probes

1 reference

12 December 2020

Phase I-II study of pegylated liposomal cisplatin (SPI-077) in patients with inoperable head and neck cancer

1 reference

12 December 2020

A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors

1 reference

12 December 2020

Acute nephrotoxicity as an adverse effect after intraperitoneal injection of massive amounts of bioactive ceramic powders in mice and rats

1 reference

12 December 2020

Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system

1 reference

12 December 2020

Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells

1 reference

12 December 2020

Homogeneous detection of nucleic acids based upon the light scattering properties of silver-coated nanoparticle probes

1 reference

12 December 2020

Mesoporous silica microparticles enhance the cytotoxicity of anticancer platinum drugs

1 reference

12 December 2020

Photopatterned Hydrosilylation on Porous Silicon

1 reference

12 December 2020

Clinical and pharmacological studies with cis-diamminedichloroplatinum (II)

1 reference

12 December 2020

Identifiers

DOI

10.1002/SMLL.201100438

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

21630444

1 reference